Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

Silver Shatters Records with Historic 70% Surge

Robert Sasse by Robert Sasse
October 11, 2025
in Commodities, Gold & Precious Metals, Trading & Momentum
0
Silber Stock
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

After a 45-year wait, silver has finally achieved what many market experts considered impossible. On Thursday, the white metal soared to an unprecedented $51.30 per ounce, establishing a landmark price level that signals a new era for the precious metal. This breakthrough follows an explosive 70 percent rally since the beginning of the year, catapulting silver into entirely new valuation territory.

Industrial Demand Reaches Unprecedented Levels

Multiple industrial sectors are driving consumption to record highs:

  • Solar Power: Consumption has doubled since 2020
  • Electric Vehicles: Exploding demand for electrical systems
  • 5G Infrastructure: Massive investments are fueling need
  • Consumer Electronics: Continuous growth in usage

Structural Supply Shortage Intensifies

The fundamental driver behind this historic move is a dramatic supply-demand imbalance. For the fifth consecutive year, global demand has substantially outpaced available supply. This scarcity is particularly acute in London, where lending rates for physical silver have skyrocketed to an extraordinary 11 percent.

Simultaneously, unusual market distortions have emerged. While spot silver trades around $50, Comex futures are priced near $48. This gap exceeding two dollars enables profitable arbitrage opportunities and underscores the extreme tension within markets.

Should investors sell immediately? Or is it worth buying Silber?

Geopolitics Fuel Safe-Haven Rally

Ongoing uncertainty regarding US fiscal policy, persistent tensions between the United States and China, and political instability in both France and Japan are driving increased investor flows into precious metals. A significant catalyst was the official designation of silver as a critical mineral by the United States in August.

A market paradox highlights the complex situation: Comex warehouses hold 526.1 million ounces of silver—enough to cover four years of US demand. Meanwhile, London faces an acute physical shortage. This geographical mismatch is amplifying existing price distortions.

Analysts Target $60 Per Ounce

Market researchers at Emkay see further potential, forecasting additional gains of 20 percent to reach $60 per ounce. They base this projection on the persistently strong industrial demand set against a structural supply deficit.

Historical context reveals the scale of silver’s potential. When adjusted for inflation, the 1980 all-time high would equate to approximately $200 per ounce today. Despite current record levels, this rally may represent only the beginning. With a year-to-date advance exceeding 57 percent, silver has even outperformed gold, establishing itself as the strongest precious metal of 2025.

Ad

Silber Stock: Buy or Sell?! New Silber Analysis from February 8 delivers the answer:

The latest Silber figures speak for themselves: Urgent action needed for Silber investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 8.

Silber: Buy or sell? Read more here...

Tags: Silber
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Rock Tech Lithium Stock
Analysis

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Graftech Stock
Commodities

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Hbt Financial Stock
Analysis

HBT Financial Stock Surges as Strategic Acquisition Nears Completion

February 7, 2026
Next Post
Novo Nordisk Stock

Danish Pharma Giant's Contradictory Strategy Sparks Investor Concern

Asml Stock

ASML Navigates Leadership Transition Amid Geopolitical Headwinds

BASF Stock

BASF's Landmark Deal: Strategic Masterstroke or High-Stakes Gamble?

Recommended

Camping World Stock

Can Camping World Maintain Its Dividend Amid Market Pressures?

5 months ago
Trinity Biotech Stock

Trinity Biotech Faces Critical Nasdaq Compliance Deadline

5 months ago
DVY stock news

Amarin Strengthens Position and Maximizes Shareholder Value Through Share Repurchase Agreement with Cantor Fitzgerald

2 years ago
ASTeMobile Stock

ASTeMobile Shares Face Mounting Pressure as Investor Confidence Wanes

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Trending

Cassava Sciences Stock
Analysis

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

by Jackson Burston
February 8, 2026
0

The future of Cassava Sciences appears uncertain following the definitive termination of its Alzheimer's disease program. Detailed...

DroneShield Stock

DroneShield Shares Face Headwinds Despite Record Performance

February 8, 2026
Rock Tech Lithium Stock

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Puma Biotechnology Stock

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays
  • DroneShield Shares Face Headwinds Despite Record Performance
  • Rock Tech Lithium: Investors Await the Final Go-Ahead

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com